304.18
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Waters Corp Aktie (WAT) Neueste Nachrichten
BD’s biosciences & diagnostics unit in $17.5B merger with Waters - BioWorld MedTech
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures - Reuters
Waters’ Merger With BD Biosciences & Dx Brings Growth Potential Alongside Trade-Offs, Analysts Say - insights.citeline.com
Stock Movers: Waters, Autodesk, Palantir - Bloomberg
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRM, WAT, VBTX on Behalf of Shareholders - GlobeNewswire Inc.
An $18 bln health deal faces risks outside the lab - Reuters
Milford’s Waters Corp. strikes $17.5 billion deal to merge with BD’s diagnostics unit - The Boston Globe
Waters to buy Becton Dickinson unit in a $17.5 billion deal amid tariff pressures - CNBC
Waters, BD Unite in $17.5B Diagnostics Deal - USA Herald
Waters, BD Biosciences & Diagnostic Solutions to combine in $17.5B deal - MassDevice
Waters to buy multinational firm’s bioscience division for $17.5B - Worcester Business Journal
Waters and BD Biosciences & Diagnostic Solutions announce $17.5B merger - Proactive financial news
Why Waters Corporation (WAT) Stock Is Down Today - Yahoo Finance
BD biosciences business, Waters to merge in $17.5B deal - Modern Healthcare
Market movers: Autodesk, Waters, NanoViricides... - Proactive financial news
Massachusetts firm inks $17.5B merger with division of NJ company - NBC Boston
Waters inks $17.5B merger with division of BD - The Business Journals
Waters Corporation agreed to acquire Biosciences and Diagnostics Solutions from Becton, Dickinson and Company for $17.5 billion. - MarketScreener
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - The Wall Street Journal
Transcript : Becton, Dickinson and Company, Waters CorporationM&A Call - MarketScreener
Kirkland, Wachtell Guide $17.5B Waters-BD Life Sciences Deal - Law360
What to Expect From Waters Corporation's Next Quarterly Earnings Report - inkl
Becton to merge unit with Waters in $17.5 billion deal - MarketScreener
Why is Waters Stock Down On Monday?Becton Dickinson (NYSE:BDX), Waters (NYSE:WAT) - Benzinga
Becton Dickinson gets its spinoff deal, but the stock is still falling - MarketWatch
Becton to merge biosciences and diagnostics arm with Waters in $17.5 billion deal - MSN
Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal - MSN
Waters Corporation (WAT) Announces Strategic Merger with Becton, - GuruFocus
Waters to merge with Becton's biosciences and diagnostics arm in $17.5 billion deal - MSN
Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal - The Wall Street Journal
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing - PR Newswire
Beyond the Lab: The BD-Waters Merger and Its Synergistic Promise in Life Sciences - AInvest
Waters stock falls after announcing $17.5B merger with BD Biosciences unit - Investing.com
Becton to Merge Biosciences and Diagnostics Arm With Waters in $17.5 Billion Deal - US News Money
A New Era in Life Sciences: Waters and BD's Merger as a Catalyst for Dominance in Regulated Testing Markets - AInvest
Waters, BD's Bioscience & Diagnostics Solutions Business to Combine - MarketScreener
WAT to Combine With BD Diagnostics Unit – Strategic 8-K Announcement | WAT SEC FilingForm 8-K - Stock Titan
BD And Waters Join Forces In A $17.5 Billion Merger - Finimize
Becton Dickinson Spins Off Biosciences In $17.5 Billion Waters Deal - Finimize
Waters Corporation Trading Volume Surges 44.41% to 2 Billion Shares, Ranks 463rd Despite Slight Stock Price Decline - AInvest
Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call - MarketScreener
Global Analytical Instruments Leader Waters Corporation Announces Q2 2025 Earnings Call Details - Stock Titan
What To Expect From Waters Corporation's Next Quarterly Earnings Report - Barchart.com
Scotiabank Adjusts Price Target on Waters to $465 From $450, Maintains Sector Outperform Rating - MarketScreener
Waters to Merge with BD's Life Science and Diagnostics Business - Morningstar
Why Waters Corporation (NYSE:WAT) Could Be Worth Watching - Yahoo Finance
Waters Corp. outperforms biotech peers after CEO takes a back-to-basics approach - The Business Journals
Winners And Losers Of Q1: Waters Corporation (NYSE:WAT) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Waters Corporation Slumps to 484th in Trading Volume with 1.84 Billion Shares Exchanged - AInvest
The 5 Most Interesting Analyst Questions From Waters Corporation’s Q1 Earnings Call - Yahoo Finance
Waters stock price target reiterated at $400 on EV battery testing growth - Investing.com India
How Is Waters Corporation's Stock Performance Compared to Other Healthcare Stocks? - MSN
Waters launches enhanced HPLC system with user authentication By Investing.com - Investing.com South Africa
Waters launches enhanced HPLC system with user authentication - Investing.com
Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity – Company AnnouncementFT.com - Financial Times
Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity - PR Newswire
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
Here's Why Waters (WAT) is a Strong Growth Stock - Yahoo Finance
Waters (NYSE:WAT) Rating Lowered to Hold at Wall Street Zen - Defense World
Waters Introduces Xevo TQ Absolute XR Mass Spectrometer at ASMS - Chromatography Online
Deutsche Bank Adjusts Price Target on Waters to $375 From $395 - marketscreener.com
Transcript : Waters Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08 - marketscreener.com
Waters sets a new benchmark for robustness and sensitivity for high-throughput labs with the Xevo TQ Absolute XR Mass Spectrometer - SelectScience
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):